Search

Search Constraints

You searched for: Author/Creator Gillmore, Julian D

Search Results

1. 001 Multiparametric mapping to understand pathophysiology in cardiac amyloidosis. (3rd April 2017)

2. 008 Demonstration of cardiac AL amyloidosis regression after succesful chemotherapy. a CMR study. (3rd April 2017)

3. 024 Spectrum and significance of CMR findings in cardiac transthyretin amyloidosis. (3rd April 2017)

4. 028 Routine identification of hypoperfusion in cardiac amyloidosis by myocardial blood flow mapping. (3rd April 2017)

5. 137 PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY. (15th December 2022)

6. 172 CLINICAL AND PROGNOSTIC IMPLICATIONS OF RV UPTAKE WITH RADIONUCLIDE SCINTIGRAPHY IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS. (15th December 2022)

7. 189 PREVALENCE, DISEASE CHARACTERISTICS AND OUTCOMES OF HEREDITARY TRANSTHYRETIN AMYLOID CARDIOMYOPATHY AMONG ELDERLY INDIVIDUALS. (15th December 2022)

8. 77 HELIOS-A: 18-MONTH EXPLORATORY CARDIAC RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS. (15th December 2022)

9. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. (13th July 2021)

10. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. Issue 4 (30th January 2015)